Found: 34
Select item for more details and to access through your institution.
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1343, doi. 10.1177/10781552221119797
- By:
- Publication type:
- Article
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 4, p. 850, doi. 10.1177/10781552211005525
- By:
- Publication type:
- Article
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 4, p. 943, doi. 10.1177/1078155219895079
- By:
- Publication type:
- Article
To do or not to do: A concise update of current clinical controversies in immune checkpoint blockade.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 3, p. 663, doi. 10.1177/1078155218786365
- By:
- Publication type:
- Article
An update on current and emerging therapies for epithelial ovarian cancer: Focus on poly(adenosine diphosphate-ribose) polymerase inhibition and antiangiogenesis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 6, p. 454, doi. 10.1177/1078155216657165
- By:
- Publication type:
- Article
Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 3, p. 461, doi. 10.1177/1078155215577810
- By:
- Publication type:
- Article
Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: A systemic review of current development, evidence, and recommendation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 1, p. 11, doi. 10.1177/1078155212474047
- By:
- Publication type:
- Article
Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 4, p. 475, doi. 10.1177/10600280211036154
- By:
- Publication type:
- Article
New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 330, doi. 10.1177/1060028020941852
- By:
- Publication type:
- Article
Targeting the androgen receptor signaling pathway in advanced prostate cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 15, p. 1224, doi. 10.1093/ajhp/zxac105
- By:
- Publication type:
- Article
Misconception on the duration of ado-trastuzumab emtansine treatment for HER2-positive early breast cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 10, p. 717, doi. 10.1093/ajhp/zxac008
- By:
- Publication type:
- Article
From oxygen sensing to angiogenesis: Targeting the hypoxia signaling pathway in metastatic kidney cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2020, v. 77, n. 24, p. 2064, doi. 10.1093/ajhp/zxaa308
- By:
- Publication type:
- Article
Current targeted therapies in lymphomas.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 22, p. 1825, doi. 10.1093/ajhp/zxz202
- By:
- Publication type:
- Article
Instilling value, quality, and safety through hematology and oncology stewardship.
- Published in:
- American Journal of Health-System Pharmacy, 2019, v. 76, n. 9, p. 617, doi. 10.1093/ajhp/zxz036
- By:
- Publication type:
- Article
Restoring the switch for cancer cell death: Targeting the apoptosis signaling pathway.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 13, p. 945, doi. 10.2146/ajhp170607
- By:
- Publication type:
- Article
Implementation of an integrated computerized prescriber order-entry system for chemotherapy in a multisite safety-net health system.
- Published in:
- American Journal of Health-System Pharmacy, 2018, v. 75, n. 6, p. 398, doi. 10.2146/ajhp170251
- By:
- Publication type:
- Article
Management of neuroendocrine tumors.
- Published in:
- American Journal of Health-System Pharmacy, 2016, v. 73, n. 21, p. 1729, doi. 10.2146/ajhp150373
- By:
- Publication type:
- Article
Importance of ethnicity and smoking status in EGFR gene testing in lung cancers.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Trametinib: A novel signal transduction inhibitor for the treatment of metastatic cutaneous melanoma.
- Published in:
- American Journal of Health-System Pharmacy, 2015, v. 72, n. 2, p. 101, doi. 10.2146/ajhp140045
- By:
- Publication type:
- Article
Omacetaxine for treatment-resistant or treatment-intolerant adult chronic myeloid leukemia.
- Published in:
- American Journal of Health-System Pharmacy, 2014, v. 71, n. 4, p. 279, doi. 10.2146/ajhp130506
- By:
- Publication type:
- Article
Ziv-aflibercept: A novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 21, p. 1887, doi. 10.2146/ajhp130143
- By:
- Publication type:
- Article
Pertuzumab for the treatment of human epidermal growth factor receptor type 2-positive metastatic breast cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 18, p. 1579, doi. 10.2146/ajhp120735
- By:
- Publication type:
- Article
Development and implementation of an interdisciplinary oncology program in a community hospital.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Sequencing and combination of current small‐molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence?
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 1, p. 15, doi. 10.1111/ejh.13973
- By:
- Publication type:
- Article
Current therapies for classic myeloproliferative neoplasms: A focus on pathophysiology and supportive care.
- Published in:
- American Journal of Health-System Pharmacy, 2023, v. 80, n. 22, p. 1624, doi. 10.1093/ajhp/zxad181
- By:
- Publication type:
- Article
Paraneoplastic syndromes: A focus on pathophysiology and supportive care.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 22, p. 1988, doi. 10.1093/ajhp/zxac211
- By:
- Publication type:
- Article
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2022, v. 12, p. 99, doi. 10.2147/BLCTT.S282247
- By:
- Publication type:
- Article
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 9, p. 1052, doi. 10.1002/phar.1977
- By:
- Publication type:
- Article
Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 1, p. 129, doi. 10.1002/phar.1871
- By:
- Publication type:
- Article
Ibrutinib, Obinutuzumab, Idelalisib, and Beyond: Review of Novel and Evolving Therapies for Chronic Lymphocytic Leukemia.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 12, p. 1298, doi. 10.1002/phar.1509
- By:
- Publication type:
- Article
Non-parametric Bayesian approach to post-translational modification refinement of predictions from tandem mass spectrometry.
- Published in:
- Bioinformatics, 2013, v. 29, n. 7, p. 821, doi. 10.1093/bioinformatics/btt056
- By:
- Publication type:
- Article
Computational refinement of post-translational modifications predicted from tandem mass spectrometry.
- Published in:
- Bioinformatics, 2011, v. 27, n. 6, p. 797, doi. 10.1093/bioinformatics/btr017
- By:
- Publication type:
- Article
Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Older adults may not consider life expectancy an important factor in cancer screening.
- Published in:
- 2018
- By:
- Publication type:
- journal article